LONDON (AP) — Drugmaker GlaxoSmithKline sank to a fourth-quarter loss of 546 million pounds ($758 million) from a profit of 257 million pounds a year earlier, as it dealt with U.S. tax changes. The deterioration came despite a 1 percent rise in sales to 7.6 billion pounds. CEO Emma Walmsley said Wednesday that the company is bracing for competition in the coming year in its core respiratory and HIV businesses.

Topics:  london ap     drugmaker glaxosmithkline   ceo emma walmsley   advair   trelegy ellipta   copd   shingrix   hiv   loss   tax   million   pounds   company   year   

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News